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Abstract Over the last 200 years, humans experienced a huge increase of life
expectancy. These advances were largely driven by extrinsic improvements of their
environment (for example, the available diet, disease prevalence, vaccination, and
the state of hygiene and sanitation). In this paper, we ask whether future improve-
ments of life expectancy will be bounded from above by human life span. Life span,
in contrast to life expectancy, is conceptualized as a biological measure of longevity
driven by the intrinsic rate of bodily deterioration. In order to pursue our question, we
first present a modern theory of aging developed by bio-gerontologists and show that
immutable life span would put an upper limit on life expectancy. We then show for a
sample of developed countries that human life span thus defined was indeed constant
until the mid-twentieth century but increased since then in sync with life expectancy.
In other words, we find evidence for manufactured life span.
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1 Introduction
For economists, human life span is a given constant. It is the upper bound T that we
put on top of the integral or sum sign when we compute expected lifetime utility of
a representative agent. Life span differs conceptually from life expectancy. Although
we frequently treat life- expectancy, a measure, which depends on the probability
to survive from one period to the next, as a constant, this is an assumption made
“for convenience”, since survival depends certainly on the macroeconomic environ-
ment (GDP per capita, doctors per square kilometer, etc.) and on individual economic
decisions (nutrition, health expenditure, etc.).
While most of economic theory is based on the simplifying assumptions of either
certain survival until a given end of life or a given age-unrelated survival probabil-
ity per time unit of life (based on Yaari 1965 and Blanchard 1985), there exists also
a, by now, rich literature that tries to endogenize survival and to incorporate empir-
ically plausible survival probabilities into economic reasoning. To the best of our
knowledge, however, there exists no research in economics on human life span.1
With contrast to life expectancy, which is population specific and situation spe-
cific, life span is usually conceptualized as a species-specific characteristic (Arking
2006; Gavrilov and Gavrilova 1991). Life expectancy of a population of mice, for
example, depends on the specific environment in the wild or in the laboratory. Life
span of mice, in contrast, is independent from such conditions but it differs from the
life span of fruit flies or elephants. Likewise, life expectancy of a particular human
population differs across countries (England vs. Uganda) and over time (England
today vs. 200 years ago). Life span of human beings, however, if it exists, should be
invariant across populations. Probably all biologists agree to this notion of life span.
But how to measure life span is—in contrast to life expectancy—less easily agreed
upon.
Defining human life span as the maximum attainable age at death, as suggested
in many general dictionaries and many older contributions in biology, is certainly
misleading (Wilmoth 1999; Carey 2003). Conceptually, this idea is refuted by the
insight that “however old we are, our probability to die within the next hour is never
equal to one” (Jacquard 1982). Empirically, it has been refuted by the observation
that maximum age at death has been continuously on the rise for at least 140 years
(Wilmoth and Robine 2003).
The simple fact that the “sample size” of people who ever lived on earth is con-
tinuously rising lets us expect that the maximum ever-observed life length will rise
1For economic theory with realistic survival probabilities, see, for example, Bu¨tler (2001), Boucekkine
et al. (2002), French (2005), Bloom et al. (2007), Bullard and Feigenbaum (2007), Hansen and
Imrohoroglu (2008), Heijdra and Romp (2008, 2009), and Kalemli-Ozcan and Weil (2010). A few eco-
nomic papers, among them Ben-Porath (1967), Cervellati and Sunde (2005), and Hazan (2009), could be
interpreted as studies on the economic impact of increasing life span, although they rarely call it so and
ignore its biological foundation.
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as time proceeds. This is impressively shown by Finch and Pike (1996). They define
life span T as the estimated age at death of the last survivor of a population such that
S(x) = 1/N is the probability to be the last man standing out of N . Plugging 1/N
into an empirically estimated Gompertzian survival function, they obtain a life span
of 105 years for N = 103 and 114 years for N = 107. In general, the dependence
of maxima on sample size is a well-known fact of the statistics of extreme values
(Gumbel 1958).
From these observations, it should be clear that life span, in contrast to life
expectancy, cannot be defined as a mere statistical measure without biological foun-
dation. We need some understanding about the biological mechanism of aging in
order to infer an intrinsic mechanism that governs the pace at which our bodies dete-
riorate. Following standard reasoning in modern biology by taking aging and death
as stochastic processes (Arking 2006), we are interested in whether a regularity exists
which is common to all humans independently from environmental and genetic char-
acteristics. From this regularity, if it exists, we try to infer life span not as an absolute
maximum but as the characteristic length of life.2
We begin our pursuit of human life span in Section 2 by introducing two very
strong empirical regularities, the Gompertz–Makeham law of mortality and the
compensation effect of mortality. These empirical regularities are theoretically sup-
ported by reliability theory as shown by Gavrilov and Gavrilova (1991) and other
bio-gerontologists. This led to the development of a novel theoretically founded
conceptualization of human life span. We sketch the essence of this theory and its
consequences in Section 2.3. The most important quantitative implication is that
human life span can be inferred from the estimated compensation effect of mortal-
ity. In Section 3, we show that human life span if it was immutable would lead to a
rectangularization of the survival curve and thus would put an upper bound on future
advances of human longevity.
In Section 4, we estimate the parameters of the Gompertz–Makeham equation
using the method of nonlinear least squares and data on age-specific mortality rates
from the Human Mortality Database (2010). We then use the estimated parameters to
analyze the compensation effect of mortality and infer human life span. We observe
a time-invariant compensating effect until the mid-twentieth century for all countries
in our sample. For the second half of the twentieth century, we find evidence for a
secular increase of human life span. In other words, we find that human ingenuity has
effectively interfered with nature and has created “manufactured lifetime” (Carnes
and Olshansky 2007). Finally, we show that life expectancy in the second half of the
last century increased in sync with life span. To a large and increasing extent, we are
2Notice that our analysis at the population level cannot be generalized to population subgroups. Olshansky
SJ et al (2012), for example, document diverging trends in life expectancy by socioeconomic status and
race for the USA. In 2008, college educated white males lived more than 14 years longer than black males
with less than high school education. For women, this difference is still more than 10 years. Avendano
et al. (2011) points out that highly educated Americans are relatively similar to Europeans in terms of
life expectancy, while the gap is quite large at lower education levels. One possible explanation for these
stylized facts is different access to universal health care in Europe and the USA. Strulik (2011) proposes an
explanation of the rising education gradient in an economic life cycle model with endogenous educational
choice.
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living longer because technological progress has changed the way we age and the
way our bodies decay.
Our study continues the work of Strehler and Mildvan (1960) and Gavrilov and
Gavrilova (1991). Compared to these earlier works, we used a larger sample consist-
ing of more countries and covering a much longer period of time. This allowed us
not only to confirm the earlier result of a time-invariant compensating effect (time-
invariant life span) until the mid-twentieth century but also, based on new data from
the late twentieth century, to derive the novel result of a secular increase of human
life span. This finding in turn allowed us to offer a novel explanation for the obser-
vation of “broken limits to life expectancy” (Oeppen and Vaupel 2002): since about
the 1970s, later born humans can expect to live longer at least partly because human
life span itself is on the rise.
2 Human life span: theory
2.1 The Gompertz–Makeham law of mortality
All theories of human life span are based on a very strong empirical regular-
ity, the Gompertz–Makeham law of mortality. It originates from actuary Benjamin
Gompertz (1825) who observed that there exists a long period of life, ranging from
about 30 to 90 years of age, for which age and mortality are log-linearly related. Let
μ(x) denote the force of mortality, that is the conditional probability to die at age x
with a given survival of up to age x. The Gompertz law is then formally stated as
μ(x) = R exp(αx). Noting that not all causes of death are age-related, Makeham
(1860) added a constant, A ≥ 0, which provides the famous Gompertz–Makeham
formula:
μ(x) = A + Reαx. (1)
Taking both simplicity and precision into account, the Gompertz–Makeham for-
mula is to the present day the most appropriate, concise, and widely used formal
description of aging (Olshansky and Carnes 1997). Its parameters are estimated with
great precision with R2 above 0.9 not only for humans but also for species as dif-
ferent as yeast, fruit flies, and horses. The estimated coefficients, of course, differ
greatly, reflecting the large variation in life span across species (Arking 2006).
Using the Gompertz–Makeham law and solving S˙(x)/S(x) = −μ(x), we obtain









From S(x), we can infer life expectancy (expected remaining years to live) at age x
as L(x) = ∫ ∞
x
S(a)da/S(x).
Over the last century, human life expectancy at birth increased by more than
20 years in most of the fully developed countries (Riley 2001). It is interesting to
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investigate how these huge improvements of human longevity are captured by the
Gompertz–Makeham law. For this purpose, it is helpful to isolate the Makeham
parameter A because it reflects age-unrelated forces of mortality, i.e., background
mortality (Bongaarts 2005) or extrinsic mortality (Carnes and Olshansky 2007). We
expect prevention, eradication, or cure of age-unrelated diseases to be reflected in
changes of A. In contrast, any progress with respect to the aging process itself would
be reflected in a change of the age-dependent Gompertz parameters R and α. As
can be seen from Eqs. 1 and 2, a lower R would mean that humans start out in bet-
ter health (in youth) and a lower α would mean that the speed of the aging process
is slowed down. However, as shown in Section 2.3, we expect that α and R do not
change independently as long as human life span is immutable.
Over the last two centuries, background mortality went down dramatically in
today’s fully developed countries (for Sweden, for example, from 5.5 · 10−3 to
4.8·10−4; Gavrilov and Gavrilova 1991). With A being close to zero, future advances
in life expectancy will have to come from improvements of age-dependent mortality.
In other words, if technological progress could affect only background mortality but
not the intrinsic rate of bodily decay, the observed trend of improving life expectancy
at birth by about 3 months per year of birth (Oeppen and Vaupel 2002) would not be
sustainable in the future. Inspired by this fact, some gerontologists have concluded
that future life expectancy at birth will unlikely exceed 85 years (Fries 1980; Carnes
and Olshansky 2007). The problem with such a hypothesis is that—although the vir-
tually zero background mortality leaves no scope for improvement—we cannot (yet)
see any slowdown or convergence of life expectancy in the data (Wilmoth 1997,
1999). This means that recent advances of life expectancy must have originated from
a process that is reflected by a change of the Gompertz parameters.
2.2 The compensation effect of mortality
The Gompertz parameters α and R, which are estimated with high precision for a
given population, differ actually across sexes, across countries, and over time. This
means that, while all humans seem to age according to a common general law of
mortality, the specific parameters governing this law depend on sex, provenance, and
time. Furthermore, R and α seem to depend also on geography and tend to fall (in
the case of R) or rise (in the case of α) with economic development. Because of their
instability, the Gompertz parameters as such are thus not suitable to identify human
life span.
The Gompertz parameters, however, are not changing independently from each
other but, strikingly, in a specific way such that they preserve an inverse association
between α and the log of R. This fact is known as the Strehler–Mildvan correla-
tion or the compensation effect of mortality (Strehler and Mildvan 1960; Gavrilov
and Gavrilova 1991). It is exemplarily shown for Sweden in Figs. 1 and 2. Figure 1
shows the long-run trends for α and R. Over time, the slope parameter α tends to rise
and the level parameter R tends to fall. This means that, over time, Swedish women
tend to age at a faster speed but start out at lower initial mortality. Below we show
the generality of this phenomenon across countries and how it can be explained by
increasing initial redundancy in the reliability theory of aging.
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Fig. 1 Aging trends for Swedish females in 1751–2005. Left panel: Development of α over time. Right
panel: Development of R over time
Formally, the compensation effect of mortality states that
log(Rit ) = log(M) − αit · T (3)
in which Rit and αit are the population- and year-specific parameters of the Gompertz
law and M and T are invariant parameters of the compensation effect of mortality.
Figure 2 shows the correlation for Swedish females and males.
To see how the compensation effect inspired a general theory of human aging,
insert Eq. 4 into country- and sex-specific age-dependent mortality μxi ≡ μ(x)−A =
Ri exp(αix) to obtain
μx = Meα(x−T ). (4)
Observe that age-dependent mortality exhibits a fixed point. Equation 4 predicts that
all men (and likewise all women) of a country’s population share a common force
of mortality M at age T independently from the year or century of birth. In other
words, any improvement in the initial force of mortality μ0 is compensated by a
faster increase of μx with age. The final step in the derivation of human life span is
to conclude that T is approximately constant across countries. This has been found
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Fig. 2 The compensation effect of mortality in Sweden in 1751–2005. Correlation between log(R) and
α for males (right) and females (left). Observations before 1950 are marked blue, and observations after
1950 are marked red
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focal point (T ,M) as a species-specific constant. For humans, the point estimate
was T = 95 years, identified by Gavrilov and Gavrilova as “the life span of human
beings.”
The difference between the Strehler–Mildvan correlation and the compensation
effect is that Strehler and Mildvan (1960), in their original approach, inferred the
correlation from the Gompertz law, without the Makeham amendment. In order to
infer life span properly, however, the Gompertz parameters have to be derived from
the Gompertz–Makeham law, with explicit consideration of background mortality
A. Otherwise, results would be biased and changes in the extrinsic rate of mortality
would be absorbed by the parameters governing the intrinsic rate of mortality. This
has been demonstrated by Gavrilov and Gavrilova (1991) who called the unbiased
correlation the “compensation effect of mortality.” Controlling for A is of particular
importance when background mortality is high, that is in the analysis of historical
data and of contemporaneous less developed countries.
2.3 Reliability theory
The strong regularities identified by Gompertz law and the compensation effect
suggest that all humans share a common mechanism of aging, a common process
according to which individual bodies lose function over time and bodily failures
and impairments are accumulated. The pursuit to rationalize these phenomena has
inspired an application of reliability theory, originally developed to study mechan-
ical failures in engineering (Barlow and Proschan 1975), and produced the modern
theory of aging (Arking 2006). Its main idea is based on redundancy within the
human body which is depleted over time. This notion of aging as accelerated loss
of organ reserve is in line with the mainstream view in the medical science. For
example, initially, as a young adult, the functional capacity of human organs is esti-
mated to be tenfold higher than needed for survival (Fries 1980). It accords also
well with the modern view in biology, which conceptualizes aging and death as
driven by accidental stochastic shocks on the molecular level (Arking 2006). Here,
we sketch a basic theory by Gavrilov and Gavrilova (1991, 2001) and refer to their
work as well as to Novoseltsev (2006), Finkelstein (2008), and Milne (2008) for
extensions.
A common characteristic of all reliability-based models is that organisms are con-
ceptualized as complex systems consisting of essential parts (e.g., organs, tissue)
connected in series, which are in turn built of smaller entities connected in parallel.
Parallel connectivity means that reliability theory is built upon the idea of redun-
dancy. Another common theme is a stochastic failure rate for the basic entities.
The notion of aging as driven by a stochastic process helps to explain the “unfair”
nature of human fate, i.e., why we actually observe large differences of aging at the
individual level. Reliability theory can explain why individuals raised under equal
conditions and/or built from the same genes (monozygotic twins) can age and even-
tually die in very different ways. At the same time, the model provides a toehold to
explain how population- (e.g., country-) specific characteristics and the environment
early in life have a bearing on aggregate aging behavior of entire populations and/or
subpopulations.
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Suppose an organism consists of m irreplaceable blocks, i.e., blocks connected
in series such that the organism dies if one block fails. Each block consists of n
elements, connected in parallel with age-independent failure rate λ. The probability
for a block to expire before age x is given by F(x) = [1 − exp(−λx)]n. Suppose
that many elements are initially defect. The probability of an initially functioning
element is given by q . It can then be shown that the failure rate of the organism (i.e.,
the mortality rate) is given by Eq. 5:
μ(x) ≈ Reα·x where
{
R ≡ mcλk exp(−k)
α ≡ kλ, (5)
in which k ≡ nq is the mean number of initially functioning elements and c is a
constant to provide a unitless result. The model thus explains Gompertz’ law. Taking
log’s of R, we get log(R) = log(cmkλ) − k, and inserting α = kλ, we arrive at
log(R) = log(M) − αT , with M ≡ αmc and T ≡ 1/λ. The model thus explains the
compensation effect of mortality.
For an interpretation of the result, note that T is uniquely pinned down by
λ, the age-independent failure rate of an element. If λ is a species-specific con-
stant, then the model supports a unique focal point T , i.e., a species-specific life
span. Across species, T depends inversely on the robustness of its nonaging ele-
ments. The compensation effect, according to this simple model of reliability, then
means that any variation number of initially functioning elements, k = nq , is com-
pensated by a proportional reduction of the number blocks m such that M stays
constant.
Suppose that available nutrition (for mother and child) and disease exposure early
in life have shaped k. Taking the historic improvement in nutrition and health into
account, the model then predicts that, with ongoing economic development, peo-
ple start out much better at young age but are aging faster. Consequently, survival
prospects and life expectancy have improved at any age up to age T .
In other words, a time-invariant compensation effect of mortality would imply
that better health care and nutrition or, more generally, improvements of the eco-
nomic environment through technological progress have increased life expectancy
“only” through improving somatic redundancy (for example, more healthy body
cells; Fogel 1994; Fogel and Costa 1997). In order to improve life span T , techno-
logical progress needs to have a bearing on λ, that is on the intrinsic rate of bodily
decay.
3 Implications of time-invariant human life span
3.1 Compression of morbidity
The notion of a constant life span T is sometimes expressed as “rectangulariza-
tion” or as “compression of morbidity” (Fries 1980). These concepts are illustrated
in Fig. 3. The left panel shows an improvement of the age-dependent force of aging
according to the Strehler–Mildvan correlation. The slope parameter α increases from
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Fig. 3 Aging under compensation of mortality. A = 0.002, α = 0.08 (blue lines) and α = 0.11 (red
lines), M = exp(−0.07), R = M exp(−α · T ), T = 83
0.08 (blue line) to 0.11 (red line). This is about the actually observed average increase
for women during 20th century in our sample of countries. The level parameter R is
assumed to adjust in a way that supports a fixed point at T = 83.
The middle panel shows the implied unconditional survival rate S(x) and conveys
the idea of rectangularization. Compared to the beginning of the century, a higher
share of women reach an old age of, say, 70 years and expire then more quickly during
their last years before death. Visually, the survival curve becomes closer to rectangu-
lar over time. This implies that gains in life expectancy, for example, brought forward
by technological progress in medicine, decrease with age as well, as demonstrated in
the panel on the right-hand side of Fig. 3. Improvements in health at earlier stages
of life lead to a faster deterioration in old age, a compression of morbidity, such that
women reaching an age of T share the same force of mortality at the beginning and
at the end of the century.
For comparison, Fig. 4 shows the effect on survival and life expectancy caused by
an improving level parameter R without compensation effect. The slope parameter α
is held constant. In this case, the curves shift to the right at all ages, indicating that
aging as such has been postponed at all ages and providing a visible increase of life
expectancy also for the old (see also Vaupel 2010). In terms of theory, the inherent
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Fig. 4 Manufactured life span. A = 0.002, α = 0.011, R = 2.7 · 10−5 (blue lines), and R = 0.9 · 10−5
(red lines)
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failure rate of the elements of which humans are constructed λ has been manipulated.
Human life span T increased.
3.2 The future of longevity
In this section, we show that if the compensation effect of mortality is time invariant
and M and T are species-specific constants, then future gains of life expectancy are
bounded from above. This means that the notion of broken limits to life expectancy
(Oeppen and Vaupel 2002) inferred from extrapolation of past trends would be ill-
considered. Actually, there would exist a certain limit to life expectancy. In order to
show this, we insert the compensation effect of mortality, R = M exp(−αT ), into
Eq. 1. Assuming that A is zero (which is a reasonable approximation for contempora-
neous fully developed countries), we get the force of mortality μ = M exp[α(x−T )].
The implied survival at age x is S(x) = exp(y) exp [−M/α exp(α(x − T ))] with
y ≡ M/α exp(−αT ). For analytical simplicity, we focus on life expectancy at birth,





[−M/α exp(α(x − T ))] dx. (6)
Substituting u = M/α exp [α(x − T )] into Eq. 6 provides (Eq. 7):






du = exp(y) 1
α
(0, y) (7)
in which  is the incomplete gamma function. Applying the mean value theorem of












Thus, L(0) = 1/(αξ), implying, since y < ξ < ∞, that L(0) < 1/(αy). Taking the

















· (−αy) > 0 (8)
because L(0) < 1/(αy). That is, life expectancy and life span are positively
correlated. Analogously, we obtain ∂L(0)/∂M < 0.
If the compensation effect of mortality is time invariant and M and T are con-
stants, the only way to improve life expectancy is through α. In order to obtain the
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The sign of the derivative is ambiguous and there exists an extremum for α = α∗





1 + y + αyT . (9)






1 + y + αyT ·
[
yαT (1 + αT )2 − 1
]
.
From this, we conclude that the extremum is a maximum if




eαT ⇒ eMT · (1 + αT )2 < e1+αT .
Since the slope of the exponential function is generally steeper than the slope of
the quadratic, we conclude that, for sufficiently large α, there exists a maximum
life expectancy. This in turn means that life expectancy is effectively bounded from
above by life span. Since y converges very rapidly to zero with rising α, we expect
maximum life expectancy to be about T + 1/α∗.
Figure 5 visualizes these results for life span T = 85. As the force of mortality α
increases, the logarithm of initial mortality log(R) declines according to the compen-
sation effect (Eq. 3). This is shown by the dashed green line in Fig. 5, assuming that
M = 0.26. Accordingly, life expectancy at birth increases steeply for small α and
reaches an almost indiscernible maximum of 85.78 years at 1.27. Afterwards, life
expectancy converges towards T from above (blue solid line). The panel on the right-
hand side demonstrates robustness of this result by—hypothetically—considering
alternative survival rates M at age T . Noting that a perpetually increasing α under the
compensation effect of mortality implies a rectangularization of the survival curve






























Fig. 5 Life expectancy is bounded by life span. Left panel: Life expectancy (blue solid line) and initial
mortality log(R) under the compensation effect of mortality (Eq. 3) (green dashed line) for alternative α
and M = 0.26. The—almost indiscernible—maximum life span is assumed for α = 1.27. Right panel:
Life expectancy for alternative values of α and M. Both panels: Lifespan T = 85
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and that limα→∞ L(0) = T provides another definition of life span: it is the max-
imum life expectancy of a species under the compensation effect of mortality. This
implies that the observation of broken limits to life expectancy (Oeppen and Vaupel
2002) is actually inconsistent with a time-invariant compensation effect. In order to
allow for “unlimited” life expectancy, life span of humans must be modifiable.
4 Empirical evidence
In this section, we use the established methodology and investigate whether human
life span is constant or modifiable. For that purpose, we use data on 1×1 period death
rates from the Human Mortality Database (2010). 1 × 1 means that the data come for
single years of age in 1-year time intervals. The Human Mortality Database contains
detailed population and mortality data for 37 countries (there are multiple data series
for France, Germany, New Zealand, and the UK). The period of data coverage differs
from country to country. For Sweden, for example, data are available way back to
1751, while for Chile, data coverage starts only in 1992. We confine our analysis to
countries that have full data coverage from 1900 through 1999 (12 countries) or 1950
through 1999 (26 countries). This way, we ensure a consistent sample and that our
results are not due to changes in the sample composition.
4.1 The Gompertz parameters
We begin with estimating the parameters of the Gompertz–Makeham equation (Eq. 1)
by gender for all countries and years with the method of nonlinear least squares. It is
well known from the literature that the Gompertz–Makeham equation does not hold
for young and very old people. We thus restrict the sample to ages 30–90. Both Gom-
pertz parameters are estimated with very high precision. The R2 is around 0.99 in
all regressions. Figure A.1 in the Electronic supplementary material shows the distri-
bution of the estimated parameters divided by their respective standard errors. There
is not a single case of an insignificant α parameter. In the 1950–1999 sample, we
lose one country-year observation due to an insignificant estimate of the R parame-
ter for Finland. In the 1900–1999 sample, we lose 14 country-year observations due
to insignificant estimates of the R parameter for Finland and New Zealand.
The parameter estimates for α and log(R) are reported in Tables 1 and 2. For
better visualization, we break the data down into 25-year periods and report period
averages. The overall trend shown in Section 2 for Sweden is clearly visible across all
countries: α increases and R decreases over time. There are also interesting gender
differences: α is higher for females than for males, whereas R is higher for males
than for females. To simplify the exposition, we have computed in the bottom line
of Tables 1 and 2 the average α and R for the respective time periods and gender.
On average, α increased for females from 0.089 in 1900–1924 to 0.112 in 1975–
1999. For males, the increase is more modest, starting from 0.088 in 1900–1924
and reaching 0.091 in 1975–1999. For females, R decreased by more than one order
of magnitude from exp(−9.14) = 1.07 · 10−4 in 1900–1924 to exp(−11.70) =
8.3 · 10−6 in 1975–1999. Again, the decrease is somewhat more modest for males.
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Table 1 Slope parameter α across countries and time
Country 1900–1924 1925–1949 1950–1974 1975–1999
Male Female Male Female Male Female Male Female
Australia 0.081 0.097 0.092 0.111
Austria 0.087 0.102 0.095 0.118
Belgium 0.086 0.090 0.090 0.093 0.089 0.103 0.091 0.116
Bulgaria 0.080 0.088 0.088 0.102
Canada 0.085 0.099 0.089 0.109
Czech Republic 0.087 0.101 0.086 0.107
Denmark 0.098 0.093 0.095 0.095 0.094 0.105 0.088 0.111
England and Wales 0.078 0.081 0.086 0.092 0.085 0.100 0.089 0.106
Finland 0.090 0.094 0.076 0.090 0.084 0.100 0.087 0.114
France 0.089 0.088 0.088 0.096 0.089 0.107 0.099 0.125
Germany 0.089 0.103 0.093 0.114
Hungary 0.092 0.100 0.084 0.103
Ireland 0.089 0.095 0.088 0.103
Italy 0.085 0.079 0.095 0.095 0.093 0.103 0.094 0.119
Japan 0.088 0.100 0.101 0.124
Netherlands 0.089 0.088 0.094 0.094 0.095 0.105 0.090 0.118
New Zealand 0.079 0.084 0.090 0.092 0.085 0.101 0.089 0.108
Northern Ireland 0.085 0.093 0.086 0.103
Norway 0.100 0.100 0.100 0.102 0.096 0.107 0.094 0.119
Portugal 0.089 0.099 0.093 0.111
Scotland 0.079 0.081 0.086 0.090 0.084 0.095 0.084 0.099
Slovakia 0.094 0.103 0.084 0.107
Spain 0.088 0.099 0.097 0.120
Sweden 0.101 0.100 0.099 0.099 0.097 0.106 0.099 0.120
Switzerland 0.084 0.083 0.087 0.092 0.093 0.106 0.100 0.127
USA 0.079 0.098 0.087 0.105
Average 0.088 0.089 0.090 0.094 0.088 0.101 0.091 0.112
Summarizing, across all countries over the last century, the trend shows that people
become more healthy in young age but are aging faster as they get older.3
3In a related study, Bongaarts (2005) estimates the parameters of the Gompertz law for 14 countries during
the period 1950–2000 and finds a “nearly constant” slope parameter (α in our notation) and a secularly
falling level parameter (R in our notation). It is tempting to conclude from Bongaarts’ finding of decreasing
R that human life span has risen over the last half of the twentieth century. On a closer look, however,
this evidence is insufficient for a conclusion on human life span. Firstly, α and R are not species-specific
parameters; they vary across countries and sexes. Secondly, it is misleading to compare α and R at the
same (absolute) scale. Inspection of Eq. 1 shows that a unit change of α contributes as much to the force
of mortality as a unit change of the logarithm of R.
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Table 2 Level parameter log(R) across countries and time
Country 1900–1924 1925–1949 1950–1974 1975–1999
Male Female Male Female Male Female Male Female
Australia −8.55 −10.22 −9.73 −11.71
Austria −9.00 −10.47 −9.86 −12.09
Belgium −8.75 −9.18 −9.08 −9.56 −9.19 −10.52 −9.52 −12.00
Bulgaria −8.62 −9.36 −9.15 −10.51
Canada −9.05 −10.50 −9.57 −11.66
Czech Republic −8.90 −10.26 −8.85 −10.96
Denmark −9.90 −9.59 −9.67 −9.74 −9.74 −10.81 −9.34 −11.64
England and Wales −8.15 −8.56 −8.78 −9.51 −8.83 −10.37 −9.38 −11.20
Finland −9.05 −9.48 −8.06 −9.23 −8.70 −10.20 −9.17 −11.80
France −8.93 −9.03 −8.92 −9.74 −9.22 −10.95 −10.30 −12.97
Germany −9.13 −10.54 −9.63 −11.77
Hungary −9.33 −10.20 −8.78 −10.66
Ireland −9.19 −9.88 −9.20 −10.81
Italy −8.65 −8.18 −9.52 −9.66 −9.58 −10.58 −9.89 −12.29
Japan −9.02 −10.28 −10.55 −12.85
Netherlands −9.06 −9.10 −9.60 −9.69 −9.83 −10.87 −9.52 −12.30
New Zealand −8.43 −9.02 −9.29 −9.68 −8.92 −10.53 −9.46 −11.43
Northern Ireland −8.85 −9.80 −9.11 −10.86
Norway −10.21 −10.35 −10.27 −10.52 −9.95 −11.05 −9.83 −12.37
Portugal −9.13 −10.23 −9.67 −11.52
Scotland −8.19 −8.54 −8.73 −9.33 −8.68 −9.92 −8.86 −10.49
Slovakia −9.61 −10.45 −8.82 −10.95
Spain −9.18 −10.28 −10.15 −12.47
Sweden −10.22 −10.17 −10.03 −10.16 −9.96 −10.86 −10.26 −12.45
Switzerland −8.50 −8.52 −8.87 −9.40 −9.53 −10.83 −10.41 −13.08
USA −8.55 −10.35 −9.35 −11.29
Average −9.00 −9.14 −9.24 −9.68 −9.16 −10.40 −9.55 −11.70
4.2 Survival probability
We next use the average parameters of the Gompertz equation to compute the








Figure 6 shows the survival functions for average females and males in 1900–1924
(solid lines) and 1975–1999 (dashed lines). Two salient phenomena can be observed.
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Fig. 6 Survival function in 1900–1924 and 1975–1999. Dashed blue line: Survival function in 1975–
1999. Solid orange line: Survival function in 1900–1925
First, a rectangularization or compression of morbidity is clearly visible. In 1900–
1924, the decline of the survival probability starts already around age 20 whereas
in 1975–1999, survival probability stays close to unity until around age 40 and then
declines more rapidly than in the first quarter of the century. Second, in addition
to the rectangularization of the survival function, we observe also that the survival
function shifts to the right from period 1900–1924 to 1975–1999. The right shift is
not uniform across all ages, but clearly very old people are benefitting from improved
survival probabilities as well. As explained in Section 2, this finding is inconsistent
with a time-invariant compensation effect of mortality. It is a first indication that
human life span might be modifiable.
In Fig. A.2 in the Electronic supplementary material, we redo the analysis country
by country. We take the period averages of α and R for the first available period
and compare the obtained survival function to the survival function in 1975–1999
for each country. It turns out that the pattern that we have illustrated for averages—
rectangularization cum right shift of the survival function—is universal across all
countries.4
4.3 Human life span
The observations from the previous section suggest that life span T according to the
definition from the compensation effect of mortality is not constant but changing
over time. We substantiate this finding by estimating the compensation effect. In the
model,
log(Rit ) = β0 + β1·αit + it . (11)
β1 represents the negative life span −T and β0 represents log(M), the mortality rate
shared by all humans of age T . Exploratory data analysis in Fig. A.3 in the Elec-
tronic supplementary material suggests that the slope coefficient T indeed changes
4Yashin et al. (2001) arrive at a similar conclusion using period and cohort data for a smaller sample of
countries (France, Japan, Sweden, and the USA).
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Fig. 7 Strehler–Mildvan correlation in 1950–1999. Data points 1975–1999 (blue circles) and 1950–1974
(red diamonds). The solid lines represent the pooled OLS fit for each period. The countries in the sam-
ple are Australia, Austria, Belgium, Bulgaria, Canada, Czech Republic, Denmark, England and Wales,
Finland, France, Hungary, Iceland, Ireland, Italy, Japan, Netherlands, New Zealand, Northern Ireland,
Norway, Portugal, Scotland, Slovakia, Spain, Sweden, Switzerland, and the USA
over time. Pooling the observations over a too long period would lead to mislead-
ing results. We thus focus on the 26 countries, for which we have a full data from
1950 to 1999 and estimate Eq. 11 with pooled OLS for 1950–1974 and 1975–1999,
respectively. The result is visualized in Fig. 7. Red circles identify data points in the
1950–1974 period and blue circles reflect the 1975–1999 period. It is clearly visible
that, in the later period, an improvement of log(R) was associated with a somewhat
smaller increase of α than in the earlier period, implying that the slope—representing
human life span—increased in absolute value during the twentieth century.
Table 3 reports the estimation results. During the second half of the twentieth
century female life span increased from 88 years to about 96 years and male life
span increased from 82 years to almost 97 years. These numbers should be taken
with some caution. Pooling the data over (arbitrarily chosen) 25-year periods clearly
has some unwanted side effects if the slope coefficient changes over time. The main
Table 3 Human life span in 1950–1999
1950–1974 1975–1999
Male Female Male Female
T 82.2 87.6 96.6 96.4
(0.73) (0.86) (0.62) (0.67)
log(M) −1.90 −1.59 −0.76 −0.86
(0.06) (0.09) (0.06) (0.08)
R2 0.95 0.94 0.97 0.97
Standard errors in parentheses. The countries in the sample are Australia, Austria, Belgium, Bulgaria,
Canada, Czech Republic, Denmark, England and Wales, Finland, France, Germany, Hungary, Ireland,
Italy, Japan, Netherlands, New Zealand, Northern Ireland, Norway, Portugal, Scotland, Slovakia, Spain,
Sweden, Switzerland, and the USA
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Table 4 Human life span in 1900–1999
1900–1924 1925–1949 1950–1974 1975–1999
Male Female Male Female Male Female Male Female
T 86.9 89.0 86.5 86.4 89.7 95.2 94.7 93.5
(0.79) (0.96) (0.93) (1.28) (0.96) (1.21) (0.55) (0.58)
log(M) −1.313 −1.27 −1.42 −1.54 −1.24 −0.81 −0.95 −1.23
(0.07) (0.09) (0.08) (0.12) (0.09) (0.12) (0.05) (0.07)
R2 0.98 0.97 0.97 0.94 0.97 0.95 0.99 0.99
Standard errors in parentheses. The countries in the sample are Belgium, Denmark, England and Wales,
Finland, France, Italy, Netherlands, New Zealand, Norway, Scotland, Sweden, and Switzerland
point that we want to make here is that the slope coefficient, that is human life span,
was not time invariant.5
Expanding life span, however, is a fairly recent phenomenon. Extending the sam-
ple period over the whole last century provides supporting evidence for the notion of
invariant life span during the first half of the century. As shown in Table 4, we esti-
mate a life span of about 87 years for men and 89 years for women in the 1900–1924
period. Then, in the 1950–1974 period, female life span took off and male life span
followed in the 1975–1999 period. We interpret these results as follows. During the
first half of the twentieth century (and presumably also earlier in human history), the
data support the notion of an invariant human life span of about 87–89 years. Observ-
able improvements of life expectancy during that period originated from declining
background mortality (sanitation, vaccination) and from a reduction of R in associ-
ation of movement along the mortality compensation line, indicating better (initial)
physiological conditions (better nutrition, e.g., Fogel and Costa 1997). Then, in the
later twentieth century, “something” happened. According to reliability theory, these
events effectively manipulated the failure rate, that is the intrinsic rate of bodily
decay.
4.4 Life span and life expectancy
Finally, we would like to explore the link between life span and life expectancy
empirically. For that purpose, we estimate Eq. 11 annually from 1950 to 1999 for the
sample of 26 countries for which we have consistent data and compare it with the
5Recently, Zheng et al. (2011) arrived at a similar result. Their estimates, however, were unfortunately
based on the Gompertz equation, without the Makeham amendment. Since their sample contained many
less developed countries, the bias incurred from ignoring background mortality was potentially large (see
Gavrilov and Gavrilova 1991). This potential bias may explain why they arrived at a much higher estimate
of life span (referred to as the age of zero vitality according to the Strehler–Mildvan methodology) for a
sample containing many developing countries than we do for a sample of fully developed countries.
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Fig. 8 Life span and “frontier” life expectancy. Abscissa: Life span Tt obtained from a simple linear
cross-country regression of log(R) on α (Eq. 11). Ordinate: Frontier life expectancy taken from Oeppen
and Vaupel (2002). The solid line is a fitted spline with a 95 % confidence interval around it (shaded in
gray). Countries as for Table 3
“frontier life expectancy” calculated by Oeppen and Vaupel (2002).6 We visualize
the combined data in Fig. 8 in a simple scatter plot and add a spline fit with a 95 %
confidence interval to it.
Interestingly, life span and frontier life expectancy are virtually uncorrelated for
the first 20 years of the observation period, which further corroborates the idea of
improving life expectancy through lower background mortality or through better
health and nutrition in line with an invariant compensation effect. Then, from about
the 1970s and onwards, we observe a strong positive correlation between the two
variables, indicating that recent improvements in life expectancy were indeed driven
at least partly by expanding human life span.
The notion of an expanding human life span is helpful to rationalize why other
researchers have not (yet) observed any convergence of increasing life expectancy
(Wilmoth 1997; Vaupel 2010). Predictions of a certain limit to life expectancy—for
example, that it should not exceed 35 years at age of 50 (Olshansky et al. 1990)—
are presumably made under the wrong perception of an invariant human life span,
in which case they would have been indeed fully justified and understandable as the
analysis in Section 3.2 has shown. Unlike other species, however, humans seem to
be able to modify life span such that there is no limit of life expectancy visible in the
data.
5 Conclusions
In this paper, we have introduced to the economic science a theoretical foundation of
human life span based on two strong empirical regularities, the Gompertz–Makeham
law and the compensation effect of mortality. We have estimated the parameters of
6Frontier life expectancy is defined, according to Oeppen and Vaupel, as the life expectancy of the country,
which has the highest life expectancy in the world for a given year.
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the Gompertz–Makeham model and found a remarkable long-run trend. Contempo-
raneous humans start out as young adults much more healthy than their forefathers a
century ago but they are also aging faster. For a long time of our history, this trend
was consistent with the observation of rising life expectancy under an invariant life
span.
If life span was indeed immutable, as it presumably is for other animals, future
improvements in life expectancy would soon end. Life expectancy, as we have shown
in this paper, is bounded from above by life span. For the second half of the twen-
tieth century, however, we were able to present evidence for expanding life span. It
increased by about 8 years. For the last quarter of the twentieth century, we find fur-
thermore that life expectancy increased in sync with life expectancy, a phenomenon
that explains why other researchers have observed broken limits to life expectancy
(Oeppen and Vaupel 2002).
It is beyond the scope of the present paper to identify the cause of expanding life
span. Yet theory suggests that the potential candidates have to be fairly recent events
which manipulated the failure rate of human body parts. The most natural candidates
are probably regenerative medicine and replacement surgery. To be more concrete,
heart bypass operation and dialysis machines are two prominent examples of medical
innovations of the second half of the twentieth century which prolonged human lives
by replacing the functional performance of failed organs.
The notion of modifiable life span is important for economists, policymakers, as
well as theorists. Taking the capital T as constant may lead to severe misjudgments
about the future of population aging and the financial stability, meaningfulness, and
efficiency of social security and public health systems. Also, on the individual level,
the awareness of modifiable and potentially further rising life span beyond the “nat-
ural” improvements of life expectancy may have quite dramatic effects on life-cycle
decisions like schooling, savings, and retirement. Reconsidering the conventional
life-cycle theory and integrating the notion of expanding life span is a challenging
task for future research.
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